Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient

Maintaining therapeutic plasma tacrolimus concentrations is essential for mitigating potential solid organ transplant rejection and preventing toxic adverse side effects. While patients can benefit greatly from tacrolimus therapy, co-administration of drugs such as Paxlovid (nirmatrelvir/ritonavir)...

Descripción completa

Detalles Bibliográficos
Autores principales: Maynard, Robert D., Bates, Phillip, Korpi-Steiner, Nichole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462658/
https://www.ncbi.nlm.nih.gov/pubmed/37649541
http://dx.doi.org/10.1016/j.plabm.2023.e00322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462658/
https://www.ncbi.nlm.nih.gov/pubmed/37649541
http://dx.doi.org/10.1016/j.plabm.2023.e00322

Ejemplares similares